Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Vaccine Technology 2009 Conference

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

Royalty Financing Agreements in Pharma, Biotech and Diagnostics

New Products

Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment

Bioinformatics Market Potential

Biotechnology in the European Union; Trends, Investing & Country Profiles

China Pharmaceutical Industry: Analysis and Market Trends

European Generic Drug Market Potential

Global Biotechnology Markets Trends

Strategic Alliances in World Pharma and Biotech Markets

Understanding China's Chemical Industry

Understanding Genomics and Global Health Impacts

Understanding Pharmacogenomics

BioPortfolio | BioInformant Reports | Pharmacodynamic Assays Market Report

Pharmacodynamic Assays Market Report

Pharmacodynamic assays are assays that provide methods for quickly and easily screening cell samples for a pharmacodynamic effect to a drug or test agent. These assays inform drug development decisions by providing evidence of drug action on molecular targets.

The NCI recently requested that qualified small businesses submit proposals to develop pharmacodynamic assays for measuring a number of high-priority molecular targets. (For a list of the targets of interest to NCI, see: http://sbir.cancer.gov/). NCI's goal is to support development of new rigorous, validated assays to measure molecular-level response to treatment, especially real-time assays that could be used to rapidly assess response to treatment during clinical trials.

Pharmacodynamic assay development has become increasingly popular following recent introduction of Phase 0 trials by the FDA. Phase 0 trials are known as human microdosing studies and are designed to speed up the development of promising drugs by establishing early on whether they interact with their expected targets.

This market report characterizes the rapidly growing pharmacodynamic assays market, providing guidance for companies that wish to develop or support development of pharmacodynamic assays.

December 2008 PDF
More...
Price: $2,999.00 / €2,004.53

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions